Compare HCA Health Inc (HCA) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Inovio Pharmaceuticals Inc — how do they compare? HCA Health Inc trades at $370.33 (market cap $82.17B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). The key difference: HCA Health Inc is far larger — about 920.5× Inovio Pharmaceuticals Inc's market cap, and HCA Health Inc pays a 0.84% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| HCA | INO | |
|---|---|---|
Market Cap | $82.17B | $89.27M |
Sector | Health | Health |
52-Week High | $545.13 | $2.87 |
52-Week Low | $334.32 | $1.05 |
Enterprise Value | $131.08B | $60.28M |
Dividend Yield | 0.84% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
